Ketoangin

Ketoprofen lysine, the active ingredient in Ketoangin, is a nonsteroidal anti-inflammatory drug (NSAID) presented as an oromucosal formulation for oromucosal use. It is employed to relieve pain and inflammation in adult patients. GNH USA supplies Ketoangin as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Ketoprofen lysine acts on inflammatory pathways to provide analgesia and reduce swelling. - Pain: Provides relief of mild to moderate acute pain. - Inflammation: Decreases local inflammation in affected tissues. - Musculoskeletal pain: Alleviates discomfort associated with strains, sprains and arthritic conditions. - Dental pain: Reduces pain and swelling after dental procedures.

Adverse reactions may occur with any NSAID, ranging from mild to severe.

Common Side Effects: - Dyspepsia: stomach discomfort or indigestion. - Nausea: feeling of sickness or urge to vomit. - Headache: mild to moderate head pain. - Dizziness: sensation of light‑headedness. - Rash: mild skin irritation or redness. - Diarrhoea: loose stools.

Serious or Rare Side Effects: - Gastrointestinal ulcer or bleeding: potentially life‑threatening. - Renal impairment: reduced kidney function. - Severe hypersensitivity: including anaphylaxis. - Stevens‑Johnson syndrome: rare skin reaction. - Hepatic injury: liver enzyme elevation. - Cardiovascular events: increased risk of thrombotic events.

Before initiating therapy, consider patient‑specific risk factors and monitor appropriately. - Assess renal function: adjust use in patients with renal insufficiency. - Evaluate gastrointestinal risk: avoid in patients with active ulcer disease. - Check for hypersensitivity: discontinue if allergic reactions occur. - Use caution with anticoagulants: monitor for bleeding. - Pregnancy and lactation: consult a physician before use. - Store at ambient temperature: keep in the original container, protect from moisture and light.

Ketoprofen lysine can alter the activity of several co‑administered medicines.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): increased bleeding risk. - Lithium: elevated serum lithium concentrations. - Methotrexate: heightened methotrexate toxicity.

Moderate Interactions (Monitor Closely): - Corticosteroids: additive risk of gastrointestinal ulceration. - SSRIs: potential for increased bleeding. - Diuretics: possible changes in renal function.